Findings

What do systematic reviews say?

Refine by population, intervention, comparison or outcome
More filters
Evidence found and GRADE certainty

369 questions · 405 findings · 41 reviews

No studies found 81 · 20%GRADE not reported 50 · 12.3%Very low 57 · 14.1%Low 106 · 26.2%Moderate 93 · 23%High 18 · 4.4%

Pulse vs continuous dexamethasone therapy

Death or bronchopulmonary dysplasia at 36 weeks PMA · preterm infants at risk for bronchopulmonary dysplasia

Pulse may leads to higher death or bronchopulmonary dysplasia at 36 weeks' PMA compared with continuous dexamethasone therapy (low certainty).

1 finding from 1 review

Pulmonary artery perfusion with blood vs no perfusion during cardiopulmonary bypass

Number of participants with pulmonary events within longest · adult surgical patients with the need for cardiopulmonary bypass‐dependent heart surgery

The review found no eligible studies for this question.

1 finding from 1 review

Pulse vs continuous dexamethasone therapy

Death or abnormal neurodevelopmental outcome (various definitions) · preterm infants at risk for bronchopulmonary dysplasia

It is very uncertain whether pulse changes death or abnormal neurodevelopmental outcome (various definitions) compared with continuous dexamethasone therapy (very low certainty).

1 finding from 1 review

PUL vs TURP

Retreatment

It is very uncertain whether PUL changes retreatment compared with TURP (very low certainty).

2 findings from 1 review

PUL vs TURP

Major adverse events

It is very uncertain whether PUL changes major adverse events compared with TURP (very low certainty).

2 findings from 1 review